Novo Nordisk invests USD 2.6bn in new manufacturing facilities
The pharmaceutical company plans to build three new manufacturing facilities and to expand one factory in the Danish city of Kalundborg. Construction is anticipated to create around 400 new jobs.
by mikkel aabenhus hemmingsen
With an investment of DKK 17bn (USD 2.6bn), Novo Nordisk seeks to strengthen all of the links in its global value chain, from drug production to packaging, it announces in a press release on Monday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
